Jarushka Naidoo: Great to spend the day with the Danish young oncologists society, learning about immunotherapy toxicity
Jarushka Naidoo shared a post by FYO on X/Twitter, adding:
“Great to spend the day with the Danish young oncologists society, learning about immunotherapy toxicity
A critical area in oncology, not ‘just steroids’ Future needs: IO survivorship, long term and chronic “
Quoting FYO‘s post:
“What a day with young oncologists gathered for highlights on immunotherapy ✘ ir-toxicities. So many lessons learned from experts Christina Ruhlmann, Jarushka Naidoo et al
Thank you all 80 participants for joining and Søren Kjær, Troels Dreier Christensen,MortenHorsholt for setting up the even.”
Dr. Jarushka Naidoo is a thoracic oncologist at the Beaumont Hospital Dublin (Ireland), Professor in RCSI
and Adjunct Professor of Oncology at Johns Hopkins University. She currently serves as national lung
cancer lead for Cancer Trials Ireland. She serves on several international guideline panels including ASCO
and SITC (Society of Immunotherapy for Cancer), and is an experienced clinical trialist- having developed
and completed several investigator-initiated, industry-funded and cooperative group clinical trials. She
has received a number of grants including a young investigator award from the International Association
for the Study of Lung Cancer (IASLC), Lung Cancer Foundation of America (LCFA), and a career
development award from the National Institutes of Health (NIH) KL2-program. She is the IASLC
Communications Committee Chair.
For the video attached to the post click here.
Source: Jarushka Naidoo/Twitter and FYO/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023